Skylar Jeremias

A retrospective analysis found that lung function and weakened gas exchange have a minimal effect on sleep quality in patients with chronic obstructive pulmonary disease (COPD), suggesting that psychological mechanisms may play a larger role.

A case series found that skin-stretching external fixation devices coupled with negative pressure wound therapy was effective in treating large skin defects, suggesting that this method may be a cost-effective and safe alternative to more risky traditional methods.

Patients with chronic obstructive pulmonary disease (COPD) and chronic heart failure were adherent to an e-health self-management intervention but were often not responsive when advised to call medical personnel because of concerning symptoms.

A patient with a diabetic foot wound who underwent negative pressure wound therapy experienced good healing, reduced amputation risk, and no wound infection, suggesting the treatment method could be effective in other patients with similar wounds.

Two oncologists dive into the reasons behind physician hesitancy and unwillingness to prescribe biosimilars to patients with cancer and make suggestions on how to increase confidence in these agents.

Investigators detected potential predictors reducing a patients’ ability to receive an early diagnosis for chronic obstructive pulmonary disease (COPD), including poorer lung function, lower education levels, and residing in a rural area.

Amgen has received a letter from the FDA cautioning it against making misleading claims in advertising about its pegfilgrastim injector.

Adding a pedometer to pulmonary rehabilitation did not improve long-term physical activity in patients with chronic obstructive pulmonary disease (COPD), suggesting pedometers are not an effective strategy to boost physical activity, according to a recent study.

The price of reference products reduced each time a new biosimilar was added to a drug program’s reimbursement list, supporting the notion that reimbursing biosimilars creates more competition and lowers drug costs, according to a Polish study.

Different ulcer wound treatments were analyzed in elderly patients with multiple medical conditions, revealing that a multidisciplinary approach may be needed to ensure efficacy.

A meta-analysis of published literature confirmed that N-aceteylcysteine, a cough medication, was effective at improving symptoms and lung function of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Examination of surgical wound fluids revealed several peptides and proteins that could be useful in identifying biomarkers for wound healing and infection, potentially allowing providers to better diagnose and treat infections.

A lack of consensus for the term “immunocompromised” suggests that studies demonstrating the effectiveness of infection prevention in surgical patients at a high risk of wound infection may have limited relevancy.

An algorithm influenced by cough sound recognition and symptom reporting conducted using a smartphone was found to be effective at diagnosing patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Despite positive data showing that negative pressure wound therapy (NPWT) can help accelerate wound healing for neck and head wounds, investigators of a review found that the presence of certain comorbidities may slow healing times.

Topical and intravenous tranexamic acid (TXA) were found to significantly reduce blood loss compared with placebo in patients who have undergone bone surgery, suggesting that both administration methods may be effective at promoting wound healing.

A recent study examined the prevalence and characteristics of 3 atypical pathogens responsible for respiratory tract infections in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), as well as evaluated optimal detection methods.

Recent reports document new COVID-19 guidance for people with psoriatic disease, positive safety and efficacy results for guselkumab, and findings linking the C-Jun protein with psoriasis.

The latest news in the rheumatology space revealed potential biomarkers for differentiating psoriatic arthritis (PsA) from rheumatoid arthritis (RA), as well as other rheumatology news reported across MJH Life Sciences™.

Highlighting the latest inflammation-related news reported across MJH Life Sciences™.

Validity assessments revealed that 2 algorithms utilizing administrative claims data and electronic medical records were accurate at identifying moderate and severe events signaling acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

A report from Xcenda showed that biosimilars for 8 blockbuster reference biologics have successfully kept drug prices from increasing by an average of 56%, restoring the possibility that biosimilars could achieve significant discounts despite facing several barriers to uptake.

Older adults with chronic obstructive pulmonary disease (COPD) identified factors likely to encourage or discourage patients from utilizing different technologies to track and improve physical activity.

A panel of health care professionals reviewed published literature to develop a recommendation guide to advise providers on best practices when considering vaccinations for children with atopic dermatitis (AD) on dupilumab.

A study evaluating independent risk factors for invasive pulmonary aspergillosis (IPA) in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) validated a potential model that could help providers diagnose IPA earlier.

Investigators quelled concerns regarding whether patients with chronic obstructive pulmonary disease (COPD) would be likely to use eHealth tools after finding that most had internet access and were regular users of information technology.

Three recent conferences yielded new data on which treatment therapies are providing substantial benefits to patients and which ones are demonstrating more lackluster results.

Real-world data confirmed the clinical effectiveness of Celltrion Healthcare’s rituximab biosimilar (Truxima, CT-P10) in patients with diffuse large B-cell lymphoma (DLBCL).

Patients with ankylosing spondylitis taking secukinumab saw improvements in enthesitis, and some achieved complete resolution, suggesting the drug could be a viable option for patients intolerant of or unresponsive to other enthesitis-improving medications.

Treatable traits associated with the decline in lung function and quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD) were detected in a longitudinal study, highlighting targets that physicians can address to better individualize COPD management.